S 5571 · 119th Congress
A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Latest action
Read twice and referred to the Committee on Finance.
Sponsor
Marsha BlackburnRepublican · TNProfile →Cosponsors (3)
2 R · 1 D